Mr. Ross has over 10-years of private equity investing experience. Prior to joining NaviMed Capital in 2015, Mr. Ross was an Associate at Capitala Group, a capital provider to lower and middle-market companies through its family of funds, where he supported control equity, minority equity, and other structured investments across several industries.
He has originated, executed, and managed investments in healthcare providers, healthcare payors, medical products, and outsourced pharmaceutical services, among others. Mr. Ross currently serves on the Board of Directors for Advantage Wound & Surgical Care, CiTRUS Health Group, and Lighthouse Lab Services and is a Board Observer for OPN Healthcare. He previously served on the Board of Directors for Velocity Clinical Research (sold to GHO), The CM Group (sold to Open Health/Astorg) and was a Board Observer for CenterPointe Behavioral Health System (sold to Acadia Healthcare).
Mr. Ross holds a BS in Finance from East Carolina University and an MBA from the Wharton School, University of Pennsylvania.Email Ryan Ross